The microbial composition of the intestines is complex and varies widely from one individual to another. Many factors such as environmental factors, lifestyle, genetics or illnesses affect the intestinal ecosystem of helpful gut bacteria.
The team examined the importance of daytime-dependent fluctuations of the gut microbiome in relation to type 2 diabetes; they present their study encompassing more than 4000 people and it is the first study in this field based on a large prospective human cohort.
"In order to see whether changes in the gut microbiome allow conclusions about medical conditions, so-called prospective cohort studies are required," explained the senior author.
In these prospective cohort studies, a cross section of the population is being observed; however, none of the participants showed any signs of disease. This population is being re-examined over time. This way, researchers can find out whether a certain observation may be typical for future occurrences of diseases.
"When certain gut bacteria do not follow a day-night rhythm, so if their number and function does not change over the course of the day, this can be an indicator for a potential type 2 diabetes disease. Knowing this can improve diagnosis and outlook of type 2 diabetes," said another contributor to the study.
]
These arrhythmic bacteria - those that are not changing between day and night - are a marker for potential disease. Researchers refer to this as a risk signature. "Mathematical models also show that this microbial risk signature consisting of arrhythmic bacteria helps diagnosing diabetes," explained the first author on the study.
Primarily, the scientists analyzed data from an existing independent cohort. The diabetes-related results were validated using additional cohorts from Germany. "By comparing our data to cohorts in England, we could confirm that there is - among other things - a strong regional factor affecting the microbial ecosystem. Therefore, there is a demand for finding locally specified arrhythmic risk signatures," elaborated the senior author and emphasizes that "apart from bacteria and their variations over the course of the day, other parameters such as the body mass index play a role in being able to better predict a person's future medical conditions."
Registering the time of day when taking human fecal samples for research purposes can heavily influence disease diagnostics. "Documenting these timestamps is essential for improving risk markers," the author emphasizes.
This research substantiates the hypothesis that changes in the microbiome have an effect of nutrition-related diseases. How gut bacteria changing (or not changing) during the day affect other microbiome-associated diseases such as Crohn's disease or intestinal cancer may be subject to further scientific examination.
https://www.tum.de/nc/en/about-tum/news/press-releases/details/36118/
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(20)30343-7
Gut bacteria improve type 2 diabetes risk prediction
- 1,589 views
- Added
Edited
Latest News
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
How the brain senses body p…
By newseditor
Posted 26 Mar
Other Top Stories
Trigger for Alzheimer's disease found!
Read more
People with anxiety show fundamental differences in perception
Read more
Genetically elevated 'good' cholesterol may actually be bad
Read more
Yoga improves quality of life in patients with atrial fibrillation
Read more
Protecting against oxidative damage and improving healthspan
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
Balancing neuronal activity…
By newseditor
Posted 28 Mar
OSBP-mediated PI(4)P-choles…
By newseditor
Posted 28 Mar
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Targeting Erbin-mitochondri…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar